Benzothiadiazoles
Sigma Aldrich Fine Chemicals Biosciences Tizanidine hydrochloride >=98% (HPLC), powder | 64461-82-1 | MFCD00798231 | 10MG
Tizanidine hydrochloride >=98% (HPLC), powder | Purity: >=98% (HPLC) | Mol Wt: 290.17 | 64461-82-1 | MFCD00798231 | 10MG
Chemscene ChemScene | 2,1,3-Benzothiadiazol-4-amine | 5G | CS-W018457 | 0.97 | 767-64-6| MFCD00005810 | 151.19
ChemScene | 2,1,3-Benzothiadiazol-4-amine | 5G | CS-W018457 | 0.97 | 767-64-6| MFCD00005810 | 151.19
![Chemscene ChemScene | 4-Bromobenzo[c][1,2,5]thiadiazole | 5G | CS-W018450 | 0.98 | 22034-13-5| MFCD00614355 | 215.07](https://assets.fishersci.com/TFS-Assets/CCG/product-images/CS-W018450.jpg-250.jpg)
Chemscene ChemScene | 4-Bromobenzo[c][1,2,5]thiadiazole | 5G | CS-W018450 | 0.98 | 22034-13-5| MFCD00614355 | 215.07
ChemScene | 4-Bromobenzo[c][1,2,5]thiadiazole | 5G | CS-W018450 | 0.98 | 22034-13-5| MFCD00614355 | 215.07
eMolecules 65858-50-6 | 5-(Bromomethyl)-2,1,3-benzothiadiazole | Combi-Blocks | MFCD00544836 | 229.100 | C7H5BrN2S | 97.000 | BrCc1ccc2nsnc2c1 | 5g | 342867659
5-(Bromomethyl)-2,1,3-benzothiadiazole | Combi-Blocks | 65858-50-6 | MFCD00544836 | 229.100 | C7H5BrN2S | 97.000 | BrCc1ccc2nsnc2c1 | 5g | 342867659
![Medchemexpress LLC Ethanethioic acid S-[2-[6-[[[4-[3-(dimethylamino)propoxy]phenyl]sulfonyl]amino]-3-pyridinyl]-2-oxoet | 940943-37-3 | 98.1% | 451.56 | C20H25N3O5S2 | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000241455.png-250.jpg)
Medchemexpress LLC Ethanethioic acid S-[2-[6-[[[4-[3-(dimethylamino)propoxy]phenyl]sulfonyl]amino]-3-pyridinyl]-2-oxoet | 940943-37-3 | 98.1% | 451.56 | C20H25N3O5S2 | 5 MG
KD 5170 is a mercaptoketone-based pan inhibitor of histone deacetylases (HDACs) that exhibits broad-spectrum antitumor activity in vitro and in vivo. It is supplied as a research compound with characterized purity and physicochemical properties for preclinical studies.
- Pan inhibitor of histone deacetylases (HDACs).
- Demonstrated broad-spectrum antitumor activity in vitro and in vivo.
- High purity suitable for research applications (≈98.1%).
- Soluble in DMSO at high concentration (100 mg/mL) for in vitro assays.
- Recommended solid storage at 4°C; solutions stable at -80°C (6 months) or -20°C (1 month).
- Molecular formula C20H25N3O5S2 and molecular weight 451.56 aid compound handling and dosing.
Medchemexpress LLC FAUC 213 | 337972-47-1 | 99.9% | C18H19ClN4 | 100 MG
FAUC 213 is an orally active and highly selective dopamine D4 receptor complete antagonist. It demonstrates a Ki of 2.2 nM for the hD4.4 receptor and exhibits less activity on D2 and D3 receptors. This compound can cross the blood-brain barrier (BBB) and shows atypical antipsychotic characteristics.
- Orally active and highly selective dopamine D4 receptor complete antagonist
- Ki of 2.2 nM for hD4.4 receptor
- Crosses the blood-brain barrier (BBB)
- Exhibits atypical antipsychotic characteristics
- Inhibits p5-HT1 (Ki=1.2 μM), p5-HT2 (Ki=0.52 μM), pα1 (Ki=0.27 μM)
Matrix Scientific 4,7-DIBROMO-2,1,3-BENZOTHIAD-5
4,7-dibromo-2,1,3-benzothiadiazole Mf C6h2br2n2s Mw 293.98 Cas 15155-41-6 Mdl MFCD00658844
TARGETMOL CHEMICALS INC PI-273 10MG
Also available in 1 mg, 5 mg, 25 mg, 50 mg, 100 mg, 200 mg and bulk. Please contact Fisher for quotes. PI-273, a Substrate-Competitive, Specific Small-Molecule Inhibitor of PI4KIIalpha, Inhibits the Growth of Breast Cancer Cells Purity 98.04%
![Medchemexpress LLC 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine | 337972-47-1 | MFCD06798338 | 99.9% | 326.82 g/mol | C18H19ClN4 | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000222116.png-250.jpg)
Medchemexpress LLC 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine | 337972-47-1 | MFCD06798338 | 99.9% | 326.82 g/mol | C18H19ClN4 | 5 MG
FAUC 213 is a small-molecule research compound acting as a highly selective dopamine D4 receptor full antagonist. It is supplied as a solid for pharmacology studies and analytical use, with defined molecular properties and high reported purity suitable for reproducible in vitro and in vivo experiments.
- Highly selective dopamine D4 receptor antagonist for receptor pharmacology studies.
- High purity (~99.9%) for consistent experimental results.
- Available in milligram-scale quantities to support screening and dose-ranging studies.
- Well-characterized molecular formula and weight for formulation and calculations.
- Offered as solid and as a DMSO solution option for assay-ready formats.
Medchemexpress LLC Tet-213 TFA | 99.9% | 1704.92 | 10 MG
Tet-213 TFA is an antimicrobial peptide with broad-spectrum antibacterial activity, which can promote infected wound repair.
- Broad-spectrum antibacterial activity
- Promotes infected wound repair
- Shows significant antibacterial activity on 80% (16 of 20 strains) of *S. aureus* clinical isolates
- Strongly reduces the growth and biofilm formation of *S. aureus*